This inventor holds 1 USPTO granted patent. Top assignee: Msn Laboratories Private Limited, R&d Center. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Pavan Kumar Reddy Bandla: Innovator in Pharmaceutical Chemistry
Introduction
Pavan Kumar Reddy Bandla is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. His work is characterized by a focus on innovative solutions that address complex challenges in drug formulation.
Latest Patents
Pavan Kumar Reddy Bandla holds a patent for "Polymorphs of 4-[3-chloro-4-(n'-cyclopropyl ureido)phenoxy]-7-methoxyquinoline-6-carboxamide, its salts and process for the preparation thereof." This invention relates to novel polymorphs of the compound and an improved process for its preparation. The structural formula of the compound is represented as formula-1a, showcasing the intricate design and potential applications of this pharmaceutical innovation.
Career Highlights
He is currently associated with Msn Laboratories Private Limited, R&D Center, where he continues to push the boundaries of pharmaceutical research. His dedication to innovation has led to advancements in drug development processes, enhancing the efficacy and safety of pharmaceutical products.
Collaborations
Pavan Kumar Reddy Bandla has collaborated with esteemed colleagues such as Thirumalai Rajan Srinivasan and Eswaraiah Sajja. These collaborations have fostered a dynamic research environment, contributing to the successful development of new pharmaceutical solutions.
Conclusion
Pavan Kumar Reddy Bandla exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborative efforts highlight the importance of research and development in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile